EC Number   |
Disease |
PubMed ID  |
Title of Publication |
Category |
Confidence Level |
|---|
   3.4.21.5 | Hypertension, Portal |
3151 |
Portal hypertension and gastric lesions in the rat. |
diagnostic usage
ongoing research
unassigned |
3
1
0 |
| 3.4.21.5 | Liver Diseases |
4041 |
Platelet aggregation in portal cirrhosis. |
causal interaction
diagnostic usage
unassigned |
4
4
0 |
| 3.4.21.5 | Thrombocytopenia |
4041 |
Platelet aggregation in portal cirrhosis. |
causal interaction
diagnostic usage
unassigned |
4
4
0 |
| 3.4.21.5 | Atherosclerosis |
41337 |
The isoelectric point of thrombin and its behaviour compared to prothrombin at some solid surfaces. |
unassigned |
0 |
| 3.4.21.5 | Heart Diseases |
52896 |
Effect of anabolic steroids on plasma antithrombin III. alpha2 macroglobulin and alpha1 antitrypsin levels. |
ongoing research
therapeutic application
unassigned |
2
1
0 |
| 3.4.21.5 | Thrombosis |
65798 |
Inactivation of alpha- and beta- thrombin by antithrombin-III and heparin. |
causal interaction
therapeutic application
unassigned |
4
4
0 |
| 3.4.21.5 | Disseminated Intravascular Coagulation |
75159 |
[Use of partial thromboplastin time and thrombin time in the diagnosis of disseminated intravascular coagulation] |
diagnostic usage
therapeutic application
unassigned |
4
1
0 |
| 3.4.21.5 | Nephrotic Syndrome |
82495 |
Human alpha2-macroglobulin and its antitrypsic and antithrombin activities in serum and plasma. |
causal interaction
unassigned |
3
0 |
| 3.4.21.5 | Coronary Disease |
89993 |
Short heparin thrombin clotting time, increased fibrinogen and platelet aggregates count in coronary disease: a probable hypercoagulable state. |
diagnostic usage
therapeutic application
unassigned |
3
1
0 |
| 3.4.21.5 | Multiple Myeloma |
102100 |
[Disorders in the conversion of fibrinogen to fibrin in patients with multiple myeloma] |
diagnostic usage
unassigned |
3
0 |
